BioStem Technologies, Inc. BSEM
Set alert
1.12 USD -0.17 -13.18%
At close · Oct 30
1.19 +0.07 +6.25%
After hours · Oct 30, 7:50 PM ET
1.11 Day range 1.29
1.12 52-week range 8.20
- YTD
- -70.60%
- 1 year
- -75.86%
- Open
- 1.28
- Prev close
- 1.29
- Mkt cap
- 20.91M
- Vol
- 145.59K
- Avg vol
- 151.55K
- EPS
- 0.88
- P/E
- 1.27
- Div yield
- 0.00%
More statistics
- Low
- 1.11
- High
- 1.29
- Earnings
- Aug 12, 2024
6M chart
Signals (36)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 14, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 7, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 30, 2026 | 1 month ago |
| SMA: Bearish | Sep 29, 2026 | 1 month ago |
| SMA: Bullish | Sep 24, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 8, 2026 | 1 month ago |
| SMA: Bullish | Sep 3, 2026 | 1 month ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| SMA: Bullish | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| SMA: Bullish | Aug 24, 2026 | 2 months ago |
| SMA: Bearish | Aug 21, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 21, 2026 | 2 months ago |
| SMA: Bullish | Aug 20, 2026 | 2 months ago |
| SMA: Bearish | Aug 13, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 13, 2026 | 2 months ago |
| SMA: Bullish | Aug 12, 2026 | 2 months ago |
| SMA: Bearish | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Aug 6, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 6, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 29, 2026 | 3 months ago |
| SMA: Bearish | Jul 27, 2026 | 3 months ago |
| SMA: Bullish | Jul 24, 2026 | 3 months ago |
| SMA: Bearish | Jul 23, 2026 | 3 months ago |
| SMA: Bullish | Jul 21, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 10, 2026 | 3 months ago |
| MACD: Sell Signal | Jun 25, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 15, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 5, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 3, 2026 | 5 months ago |
| MACD: Sell Signal | May 20, 2026 | 5 months ago |
| SMA: Bearish | May 15, 2026 | 5 months ago |
| SMA: Bullish | May 12, 2026 | 5 months ago |
| MACD: Buy Signal | May 11, 2026 | 5 months ago |
Next earnings
Aug 12, 2024
Expected Aug 12, 2024. Consensus EPS estimate 0.12.
Financials — quick view
BSEM Revenue — quarterly 7.90M
BSEM Net income — quarterly -8.97M
BSEM EPS — quarterly -0.52
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2024 | Sep 1, 2024 | 0.31 | 0.32 | +0.01 | +3.23% |
| Aug 12, 2024 | Jun 1, 2024 | 0.12 | — | — | — |
| Aug 12, 2024 | Jun 1, 2024 | 0.12 | 0.30 | +0.18 | +150.00% |
| May 14, 2024 | Mar 1, 2024 | 0.74 | — | — | — |
| May 14, 2024 | Mar 1, 2024 | 0.74 | 0.20 | -0.54 | -72.97% |
| Apr 1, 2024 | Dec 1, 2023 | 0.47 | — | — | — |
News
- BioStem Technologies to Host Third Quarter 2026 Financial Results Conference Call on November 12, 2026
- BioStem Technologies' CEO and COO Invest $1 Million in Cash Through Exercise of Stock Options
- BioStem Technologies' CEO and COO Invest $1 Million in Cash Through Exercise of Stock Options
- Century Therapeutics (NASDAQ:IPSC) and BioStem Technologies (OTCMKTS:BSEM) Financial Analysis
- BioStem Secures US Patent, Additional US And Mexico Allowances For Tissue Technologies
- BioStem Technologies Strengthens Placental Allograft and Umbilical Tissue Patent Portfolio
- BioStem Technologies Strengthens Placental Allograft and Umbilical Tissue Patent Portfolio
- BioStem Technologies Announces $3 Million Private Placement Priced At-The-Market Under Nasdaq Rules
- BioStem Technologies Announces $3 Million Private Placement Priced At-The-Market Under Nasdaq Rules
- Terminal1, the operating system built for public companies, announced today that BioStem Technologies, Inc. (NASDAQ: BSEM) has joined the Terminal1 platform
Your note
Sign in to keep a note on BSEM — it syncs with the Stock Master app.